Scholars Central

Review articlePublished 30 Oct 2023

Cervical Cancer Prevention: A Comprehensive Guide to Protecting Your Health

Authors: David William

Department of Cervical Cancer Prevention, University of SSA Technology, U.S.A

Cervical Cancer: Open Access

Volume 8 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cervical cancer remains a global public health concern, affecting the lives of countless women and their families. However, the past few decades have witnessed significant advances in the field of cervical cancer prevention. This long abstract provides an in-depth overview of the strategies, challenges, and progress made in the prevention of cervical cancer. Cervical cancer is primarily caused by persistent infection with high-risk human papillomavirus (HPV) types. Vaccination against these HPV types has emerged as a game-changing strategy in cervical cancer prevention. The introduction of HPV vaccines, such as Gardasil and Cervarix, has significantly reduced the incidence of cervical cancer by targeting the root cause of the disease. Nevertheless, global disparities in vaccine access and coverage persist, and challenges associated with vaccine hesitancy need to be addressed to maximize their impact. Screening for precancerous lesions using methods like the Papanicolaou (Pap) smear and more recently, HPV testing, is another crucial aspect of cervical cancer prevention. These screening programs have detected precancerous lesions at early stages, allowing for timely intervention. Implementation, accessibility, and the quality of screening programs vary greatly across regions, highlighting the importance of strengthening healthcare systems and expanding access to these screening methods. Education and awareness play a vital role in cervical cancer prevention. Public health campaigns have sought to dispel myths surrounding cervical cancer, its prevention, and the HPV vaccine. The importance of regular screenings and the benefits of HPV vaccination need to be effectively communicated to the public, healthcare providers, and policymakers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cervical Cancer: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCervical Cancer: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “David William”